Document is current

Article History

Received: 14 July 2023

Accepted: 17 September 2023

First Online: 6 November 2023

Declarations

:

: Each of the four study sites received Institutional Review Board or Ethics Committee approval.

: All participants signed a patient informed consent form prior to study enrollment.

: Not applicable.

: All authors received support from Biosense Webster, Inc. for this manuscript. Laurent Macle has received grants or contracts from Abbott Medical, Medtronic, and Servier; has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Biosense Webster, Inc., Abbott Medical, Medtronic, and Servier; has participated on a Data Safety Monitoring Board or Advisory Board for Biosense Webster, Inc.; and is president of the Canadian Heart Rhythm Society. Girish M. Nair has received grants or contracts from Biosense Webster, Inc., the Canadian Institutes of Health Research, Medtronic, and the University of Ottawa Heart Institute; has received consulting fees and support for attending meetings and/or travel from Boston Scientific Inc., Medtronic, and Biosense Webster, Inc.; has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Biosense Webster, Inc. and Medtronic; and has served on the Primary Writing Panel of the Canadian Cardiovascular Society for the Management of Atrial Fibrillation Guidelines Committee. Allan Skanes has received grants or contracts unrelated to the current study, consulting fees, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events, and has participated on a Data Safety Monitoring Board or Advisory Board for Biosense Webster, Inc. Martin Aguilar has received payment or honoraria for speakers bureaus from Biosense Webster, Inc. Alfredo Pantano reports no additional disclosures. Yaariv Khaykin has received consulting fees from the Canadian Heart Research Centre and EOCI Pharmacomm; has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Medtronic, Novartis, and Servier; and has received payment for expert testimony and participated on a Data Safety Monitoring Board or Advisory Board for Novartis. Atul Verma has received grants or contracts from Medtronic, Bayer, Biosense Webster, Inc., and Biotronik; has received consulting fees from Medtronic, Adagio Medical, Ablacon, Biosense Webster, Inc., Galaxy Medical, and Thermedical; and has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Medtronic and Biosense Webster, Inc. He is currently affiliated with McGill University Health Centre, Montreal, Quebec, Canada.